'Immunogenic cell death in cancer immunotherapy' - research lunch organized by Dept. HSR

The department of Human Structure and Repair hosts a series of thematic ‘research lunch’ meetings.
The 5th upcoming research lunch is about immunogenic cell death in cancer immunotherapy and will be moderated by prof. Olivier De Wever.

The concept of immunogenic cell death (ICD) is detrimental for efficient cancer immunotherapy resulting in the generation of long-term immunological memory. ICD is an umbrella term covering several cell death modalities, such as apoptosis, necroptosis and ferroptosis. In this seminar we will discuss

  • the hallmarks of ICD and its role in immunotherapy of glioma

  • the effect of induction of immunogenic ferroptosis in cancer therapy

2 lectures:

1) Dendritic cell vaccines based on photodynamic therapy induced ICD elicit Th17 cell–driven rejection of glioma
    presented by prof. Dmitri V. Krysko (Anatomy and Embryology Unit, Cell Death Investigation and Therapy Lab)

2) Immunogenic ferroptosis and where to find it ?
    presented by Iuliia Efimova (Anatomy and Embryology Unit, Cell Death Investigation and Therapy Lab)

  • Online: via MS Teams; you will receive the link to participate once you have registered 
  • Venue: Campus UZ Gent, room 5.3, entrance 46, 5th floor
  • Registration